Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. - Wikidata - wikimedia - TriplyDB

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

http://www.wikidata.org/entity/Q44278022

about

25-hydroxyvitamin D levels and the risk of mortality in the general population Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis Lanthanum carbonate: safety data after 10 years Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis The Value of the Model and Quantitative Parameters of Contrast-Enhanced Ultrasound in Judging the Severity of SHPT.Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis Observational studies versus randomized controlled trials: avenues to causal inference in nephrology.Impact of new vitamin D data on future studies and treatment.Vitamin D in Chronic Kidney Disease and Dialysis Patients.Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012.Clinical measures identify vitamin D deficiency in dialysis.Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.Calcium balance and negative impact of calcium load in peritoneal dialysis patients.Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients.Vitamin D and glucose metabolism in chronic kidney disease.Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients.A review of the reporting and handling of missing data in cohort studies with repeated assessment of exposure measures.Mineral and bone disorder in Chinese dialysis patients: a multicenter study.The noncalciotropic actions of vitamin D: recent clinical developments.Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China.Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis.Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis Oral active vitamin d treatment and mortality in maintenance hemodialysis patients.Clinical Significance of FGF-23 in Patients with CKD.Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies.Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa Heart Study)Osteo-renal regulation of systemic phosphate metabolism.Improved long-term survival of dialysis patients after near-total parathyroidectomy.An optical method for serum calcium and phosphorus level assessment during hemodialysis Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis Analysis of Adequacy of 25-Hydroxi vitamin D3 Supplementation in Patients on Hemodialysis and Parathormone, Calcium and Phosphorus Level in the Blood of These Patients The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism.Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients.

P2860

Q24650811-2385D290-3CFA-4532-BA21-0636D3D041E6 Q27002431-39F86A69-A7F4-4F5B-B7C7-7327FD8E49DB Q27011288-CB1B5610-D6BD-47D7-B24B-587A46D59164 Q28079982-6ECBFB3E-C1CD-49CF-904B-6950E05990B7 Q28306312-DD41CDE8-C4C9-46DE-97BA-9B97B8B0C933 Q30365852-8AFF4BFE-3BC0-4BC6-809D-A4ED1FE163D7 Q30408489-A93DD571-A394-45BC-A446-A00A2D40545A Q30423049-D2E2A6A6-EE31-42A0-B1FC-E7953356AE29 Q30624696-2B6F5A25-3326-4486-9133-20BE0AD8C13A Q33616582-A25BFB07-BDB1-431F-8F69-11B8452AE4C7 Q33671574-9BE4F170-89B5-462A-9B59-001B54BBA8C3 Q33684038-95E49C88-0747-4028-BF68-6C37198146CD Q33770086-48BD3251-4058-47F0-AE9B-AD166CB232DF Q33837633-0EAD0B1F-41B2-4BB9-9E17-0FAD3B527DA5 Q33859007-A65E7FE6-9CCA-4400-978F-9E5173E2AC53 Q33862710-9BD4A79D-021C-417A-AC39-0CD69E084437 Q33880308-EBF02F06-6CEE-40EF-891E-76EDAB0ED3CA Q33888428-FA1211DA-607A-4923-8D40-5046D1485DFF Q33890218-F8D3630E-EDC5-4B28-A3A7-6A0EE59F15F7 Q33899041-F81FBCA5-E1F3-4223-A0EE-7235BB0AB654 Q33932297-3A076521-AED4-42B9-8164-F761648A8FBF Q34008136-3DEC3341-01EE-4F87-A86D-2EEA385EAD78 Q34135288-D2ACC280-E474-4B0A-85F3-E46785E77514 Q34333257-8574FCBA-F794-4127-9A3D-2C3A0635C590 Q34418538-3A40E752-7D45-427A-9888-1C11EE4E523F Q34532994-7FFFFAE6-5253-40D7-819D-0716E281F619 Q34573734-C8FC1A64-2B9A-4776-AA60-D9AA23F27326 Q34610602-0898B19D-7A82-48C0-9E34-6CB3918EE1B4 Q34857892-1A77F5D0-BA2C-485A-B272-EB3B36D15999 Q34985742-DE47F054-AB8C-4198-9245-E2835355FE6E Q34989319-313AEDA6-971F-4D24-82FD-506D3932E0E1 Q34997739-F7B37EB0-40CC-4BDA-9E55-FBA01BCF9F9C Q35010606-1C2E95F4-3250-44C9-AA0E-9D2EE136F5FF Q35059741-B8EFB9F4-9850-48B0-B038-EEA9B038F3C7 Q35146504-BD372CE5-A5C1-4B67-8A31-205EBC6E969B Q35232708-F5316CDE-0521-42AC-AE5F-DF1E118CE275 Q35351243-EB97742C-935C-4D35-90B4-84191354DABF Q35507936-0F4873B2-0A2C-4C1E-AE68-FE4D71277C92 Q35573698-DAC6093E-BD53-43E3-A9F4-00D45508836C Q35573785-1901F735-166A-44DE-A78F-D58EBA418CAA

P2860

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

http://www.wikidata.org/entity/Q44278022

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Changes in serum calcium, phos ...... atients: a longitudinal study.

@en

Changes in serum calcium, phos ...... atients: a longitudinal study.

@nl

type

label

Changes in serum calcium, phos ...... atients: a longitudinal study.

@en

Changes in serum calcium, phos ...... atients: a longitudinal study.

@nl

prefLabel

Changes in serum calcium, phos ...... atients: a longitudinal study.

@en

Changes in serum calcium, phos ...... atients: a longitudinal study.

@nl

P1433

Q44278022-A23CE8D5-3F88-464B-82DE-3A03DB12EBDE

P1476

Q44278022-7128B707-4999-4EA9-BDA6-D33612D4FE6E

P2093

Q44278022-18290418-F80A-4FD1-80D7-9E981C31D7D4

Q44278022-45BA90BC-FB9C-4462-AFD8-E9118228DC14

Q44278022-489E2053-EDB9-4861-96F8-F091699DA169

Q44278022-51C0BF1D-547C-4EE1-984A-64D287F81374

Q44278022-CA535FDF-0D4C-4D50-B5AA-314477559978

Q44278022-E0A7939D-1006-410C-AA4C-C84820226B0D

Q44278022-F740E801-48DA-4DA4-A35D-0D9052392CEE

P2888

Q44278022-7EA9F44C-1674-4792-A6BE-D7B3187608D3

P304

Q44278022-3ACC34C7-7F55-4117-8EF8-896D3A6BF691

P31

Q44278022-3D23352A-595E-4B1A-BAEC-D9A12AD87459

P356

Q44278022-E3A261B5-1A7A-4D50-A647-C14282F27633

P407

Q44278022-70846C0C-3DA6-4F0B-9FA3-027BAB20F445

P433

Q44278022-EBA4C514-32D6-459C-BA84-2AD5E5F73A4E

P478

Q44278022-C14923ED-DDDF-444F-982D-D0879AF83706

P50

Q44278022-E96AAA87-5BC0-4A08-879C-A92983B027A1

P577

Q44278022-83C803BB-A567-4A0E-82B7-209B0FB9BB4A

P5875

Q44278022-78CDEA0E-F09B-4273-91F5-EE8A2C5799C5

P698

Q44278022-98CB245A-6039-4FCC-86A8-0FEB3D765A7F

P921

Q44278022-4E41872A-3B0A-4640-9F84-BB1E035E98EF

Q44278022-652BDFBA-C3BE-41C3-8ACD-43F86E6B4C92

P356

P1433

Kidney International

P1476

Changes in serum calcium, phos ...... atients: a longitudinal study.

@en

P2093

Coresh J

http://www.w3.org/2001/XMLSchema#string

Eustace JA

http://www.w3.org/2001/XMLSchema#string

Fink NE

http://www.w3.org/2001/XMLSchema#string

Klag MJ

http://www.w3.org/2001/XMLSchema#string

Melamed ML

http://www.w3.org/2001/XMLSchema#string

Plantinga L

http://www.w3.org/2001/XMLSchema#string

Powe NR

http://www.w3.org/2001/XMLSchema#string

P2888

P304

351-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.KI.5001542

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Bernard G. Jaar

P577

2006-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7043491

http://www.w3.org/2001/XMLSchema#string

P698

16738536

http://www.w3.org/2001/XMLSchema#string

P921